The role of glucocorticoids in increasing cardiovascular risk

IntroductionDifferent studies provide conflicting evidence regarding the potential for glucocorticoids (GCs) to increase the risk of cardiovascular diseases. This study performed a systematic review and meta-analysis to determine the correlation between GCs and cardiovascular risk, including major adverse cardiovascular events (MACE), death from any cause, coronary heart disease (CHD), heart failure (HF), and stroke.MethodsWe performed a comprehensive search in PubMed and Embase (from inception to June 1, 2022). Studies that reported relative risk (RR) estimates with 95% confidence intervals (CIs) for the associations of interest were included.ResultsA total of 43 studies with 15,572,512 subjects were included. Patients taking GCs had a higher risk of MACE (RR = 1.27, 95% CI: 1.15–1.40), CHD (RR = 1.25, 95% CI: 1.11–1.41), and HF (RR = 1.92, 95% CI: 1.51–2.45). The MACE risk increased by 10% (95% CI: 6%–15%) for each additional gram of GCs cumulative dose or by 63% (95% CI: 46%–83%) for an additional 10 μg daily dose. The subgroup analysis suggested that not inhaled GCs and current GCs use were associated with increasing MACE risk. Similarly, GCs were linked to an increase in absolute MACE risk of 13.94 (95% CI: 10.29–17.58) cases per 1,000 person-years.ConclusionsAdministration of GCs is possibly related with increased risk for MACE, CHD, and HF but not increased all-cause death or stroke. Furthermore, it seems that the risk of MACE increased with increasing cumulative or daily dose of GCs

Construção de um protótipo de Data Warehouse como suporte ao sistema de informação numa instituição de ensino superior

Uma das dificuldades que se verifica na extracção de informação numa organização é a falta de integração dos dados existentes dispersos em diversos formatos: ficheiros de processadores de texto, folhas de cálculo, bases de dados, entre outras fontes. A partir deste problema, este trabalho propõe a estruturação de um modelo de Data Warehouse com o objectivo de organizar, armazenar e integrar as informações provenientes de outros formatos e sistemas, numa única base de dados para uma futura utilização no suporte à tomada de decisão. Existem, neste momento, na comunidade de Data Warehousing duas principais abordagens, uma preconizada por William H. Inmon, mais centrada nos dados, e outra por Ralph Kimball, mais centrada no projecto. Assim, com a metodologia proposta foi desenvolvido um caso de estudo com a finalidade de verificar e avaliar a aplicabilidade da metodologia no Instituto Politécnico de Tomar; ABSTRACT: One difficulty that exists in the extraction of information in organizations is the lack of integration of existing data scattered in various formats: word processing files, spreadsheets, databases, among other sources. From this problem, this paper proposes to structure a model of Data Warehouse in order to organize, store and integrate information from other systems and formats in a single database for future use in supporting decision making. There are at present in the community of Data Warehousing two main approaches, one advocated by William H. Inmon, more data-centric, and one by Ralph Kimball, more focused on the project. So with the proposed methodology was developed a case study in order to verify and evaluate the applicability of the methodology at the Polytechnic Institute of Tomar

Finishing the euchromatic sequence of the human genome

The sequence of the human genome encodes the genetic instructions for human physiology, as well as rich information about human evolution. In 2001, the International Human Genome Sequencing Consortium reported a draft sequence of the euchromatic portion of the human genome. Since then, the international collaboration has worked to convert this draft into a genome sequence with high accuracy and nearly complete coverage. Here, we report the result of this finishing process. The current genome sequence (Build 35) contains 2.85 billion nucleotides interrupted by only 341 gaps. It covers ∼99% of the euchromatic genome and is accurate to an error rate of ∼1 event per 100,000 bases. Many of the remaining euchromatic gaps are associated with segmental duplications and will require focused work with new methods. The near-complete sequence, the first for a vertebrate, greatly improves the precision of biological analyses of the human genome including studies of gene number, birth and death. Notably, the human enome seems to encode only 20,000-25,000 protein-coding genes. The genome sequence reported here should serve as a firm foundation for biomedical research in the decades ahead

Female chromosome X mosaicism is age-related and preferentially affects the inactivated X chromosome

To investigate large structural clonal mosaicism of chromosome X, we analysed the SNP microarray intensity data of 38,303 women from cancer genome-wide association studies (20,878 cases and 17,425 controls) and detected 124 mosaic X events >2 Mb in 97 (0.25%) women. Here we show rates for X-chromosome mosaicism are four times higher than mean autosomal rates; X mosaic events more often include the entire chromosome and participants with X events more likely harbour autosomal mosaic events. X mosaicism frequency increases with age (0.11% in 50-year olds; 0.45% in 75-year olds), as reported for Y and autosomes. Methylation array analyses of 33 women with X mosaicism indicate events preferentially involve the inactive X chromosome. Our results provide further evidence that the sex chromosomes undergo mosaic events more frequently than autosomes, which could have implications for understanding the underlying mechanisms of mosaic events and their possible contribution to risk for chronic diseases

Female chromosome X mosaicism is age-related and preferentially affects the inactivated X chromosome

To investigate large structural clonal mosaicism of chromosome X, we analysed the SNP microarray intensity data of 38,303 women from cancer genome-wide association studies (20,878 cases and 17,425 controls) and detected 124 mosaic X events42Mb in 97 (0.25%) women. Here we show rates for X-chromosome mosaicism are four times higher than mean autosomal rates; X mosaic events more often include the entire chromosome and participants with X events more likely harbour autosomal mosaic events. X mosaicism frequency increases with age (0.11% in 50-year olds; 0.45% in 75-year olds), as reported for Y and autosomes. Methylation array analyses of 33 women with X mosaicism indicate events preferentially involve the inactive X chromosome. Our results provide further evidence that the sex chromosomes undergo mosaic events more frequently than autosomes, which could have implications for understanding the underlying mechanisms of mosaic events and their possible contribution to risk for chronic diseases

Biochemical and cellular characteristics of the

TREX2 is an autonomous nonprocessive 3 0! 5 0 exonuclease, suggesting that it maintains genome integrity. To investigate TREX2’s biochemical and cellular properties, we show that endogenous TREX2 is expressed widely in mouse tissues and human cell lines. Unexpectedly, endogenous human TREX2 is predominantly expressed as a 30-kDa protein (not 26 kDa, as previously believed), which is likely encoded by longer isoforms (TREX2 L1 and/or TREX2 L2) that possess similar capacity for selfassociation, DNA binding and catalytic activity. Site-directed mutagenesis analysis shows that the three functional activities of TREX2 are distinct, yet integrated. Mutation of amino acids putatively important for homodimerization significantly impairs both DNA binding and exonuclease activity, while mutation of amino acids (except R163) in the DNA binding and exonuclease domains affects their corresponding activities. Interestingly, however, DNA-binding domain mutations do not impact catalytic activity, while exonuclease domain mutations diminish DNA binding. To understand TREX2 cellular properties, we find endogenous TREX2 is down regulated during G2/M and nuclear TREX2 displays a punctate staining pattern. Furthermore, TREX2 knockdown reduces cell proliferation. Taken together, our results suggest that TREX2 plays an important function during DNA metabolism and cellular proliferation

Research Progress on 3D Printed Graphene Materials Synthesis Technology and Its Application in Energy Storage Field

Graphene is an ideal material for energy storage application as its excellent mechanical and physical properties. 3D printed graphene materials will be widely applied in energy storage field for its precisely controllable structure and it is easy to realize large-scale preparation. In this paper, the progress of 3D printed graphene materials synthesis technology and its application in energy storage field were reviewed. The viscosity and printability of graphene ink are key factors for realizing graphene 3D printing. Scalable preparation of graphene ink with facile process, controllable concentration and additive free will be the research focus of graphene 3D printing technologies in the future. The integrated printing of graphene energy storage devices such as graphene supercapacitor, lithium-sulfur battery and lithium ion battery is the development direction in this area